Evusheld 150 mg/1.5 mL (100 mg/mL) cilgavimab and 150 mg/1.5 mL (100 mg/mL) tixagevimab co-packaged Images
Generic Name: cilgavimab/tixagevimab
This medication has been identified as Evusheld 150 mg/1.5 mL (100 mg/mL) cilgavimab and 150 mg/1.5 mL (100 mg/mL) tixagevimab co-packaged. It is supplied by AstraZeneca.
and belongs to the drug class antiviral combinations. Evusheld 150 mg/1.5 mL (100 mg/mL) cilgavimab and 150 mg/1.5 mL (100 mg/mL) tixagevimab co-packaged is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Evusheld
- Generic Name
- cilgavimab/tixagevimab
- Strength
- 150 mg/1.5 mL (100 mg/mL) cilgavimab and 150 mg/1.5 mL (100 mg/mL) tixagevimab co-packaged
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-7442 (Discontinued)
See also:
AccessPak for HIV PEP Basic
AccessPak for HIV PEP Basic is used for HIV Infection, nonoccupational exposure, occupational ...
AccessPak for HIV PEP Expanded with Kaletra
AccessPak for HIV PEP Expanded with Kaletra is used for HIV Infection
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
AccessPak for HIV PEP Expanded with Viracept
AccessPak for HIV PEP Expanded with Viracept is used for HIV Infection
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Cabenuva
Cabenuva (cabotegravir and rilpivirine) injections are a long-acting HIV treatment used to keep HIV ...
Cimduo
Cimduo (lamivudine and tenofovir disoproxil fumarate) is used to treat HIV infection. Includes ...
Complera
Complera (emtricitabine, rilpivirine, and tenofovir) is used to treat HIV infection. Includes ...
Delstrigo
Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) is a combination, oral, antiviral ...
More about Evusheld (cilgavimab / tixagevimab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
Patient resources
Professional resources
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.